Titre : | Addiction, Vol.115, n°5 - May 2020 |
Type de document : | Bulletin : Périodique |
Paru le : | 01/05/2020 |
Année de publication : | 2020 |
Format : | 797-1003 |
Langues: | Anglais |
Note de contenu : |
CONTENTS:
- Reducing the risks of distortion in cannabis research [Editorial]. Humphreys K., Hall W.D., p. 799-801. - Should cigarette pack sizes be capped? [Addiction Opinion and Debate]. Blackwell A.K.M., Lee I., Scollo M., Wakefield M., Munafo M.R., Marteau T.M., p. 802-809. - We do not yet understand the psychological mechanisms explaining how cigarette pack size affects smoking, let alone smoking cessation. Willemsen M., Steenhuis I., p. 810-811. - Are there lessons from gambling control for tobacco control? Farrell L., p. 811-812. - The importance of loose tobacco when considering capping pack size. Moodie C., Stead M., p. 812-814. - What's in a number? Cummings K.M., p. 814-815. - Size matters but when, why and for whom? Blackwell A.K.M., Lee I., Scollo M., Wakefield M., Munafo M.R., Marteau T.M., p. 815-816. - Experimental manipulations of behavioral economic demand for addictive commodities: a meta-analysis. Acuff S.F., Amlung M., Dennhardt A.A., MacKillop J., Murphy J.G., p. 817-831. - Prevalence of respiratory conditions among people who use illicit opioids: a systematic review. Hulin J., Brodie A., Stevens J., Mitchell C., p. 832-849. - Problem drinking, wellbeing and mortality risk in Chinese men: findings from the China Kadoorie Biobank. Im P.K., Millwood I.Y., Chen Y., Guo Y., Du H., Kartsonaki C., et al., p. 850-862. - High- versus low-intensity internet interventions for alcohol use disorders: results of a three-armed randomized controlled superiority trial. Sundström C., Eék N., Kraepelien M., Fahlke C., Gajecki M., Jakobson M., et al., p. 863-874. - Commentary on Sundström et al. (2019): Digital interventions for alcohol problems - time for more research on blended therapy. Blankers M., p. 875-876. - Which adolescent factors predict alcohol misuse in young adulthood? A co-twin comparisons study. Stephenson M., Barr P., Ksinan A., Aliev F., Latvala A., Viken R., et al., p. 877-887. - Frequent intoxication and alcohol tolerance in adolescence: associations with psychiatric disorders in young adulthood. Sarala M., Miettunen J., Koskela J., Mustonen A., Rose R.J., Hurtig T., et al., p. 888-900. - Combined treatment and prevention strategies for hepatitis C virus elimination in the prisons in New South Wales: a modelling study. Bretana N.A., Gray R.R., Cunningham E.B., Betz-Stablein B., Ribeiro R., Graw F., et al., p. 901-913. - Prisons can also improve drug user health in the community. Martin N.K., Hickman M., Spaulding A.C., Vickerman P., p. 914-915. - Commentary on Bretana et al. (2020): Prevention and treatment in the prison setting will be key to achieving HCV elimination. Aspinall E.J., Fernandez-Montero J.V., p. 915-916. - Clinical effects beyond cocaine use of sustained-release dexamphetamine for the treatment of cocaine dependent patients with comorbid opioid dependence: secondary analysis of a double-blind, placebo-controlled randomized trial. Blanken P., Nuijten M., van den Brink W., Hendriks V.M., p. 917-923. - Associations between prescribed benzodiazepines, overdose death and buprenorphine discontinuation among people receiving buprenorphine. Park T.W., Larochelle M.R., Saitz R., Wang N., Bernson D., Walley A.Y., p. 924-932. - Commentary on Park et al. (2020): Buprenorphine and benzodiazepine co-prescribing- key considerations and future directions. Oliva E.M., p. 933-934. - Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions. Pacek L.R., Weinberger A.H., Zhu J., Goodwin R.D., p. 935-943. - Commentary on Pacek et al. (2019): Cannabis and major depression-a network theory proposal. Boden J.M., Monk N.J., p. 944-945. - The rise in non-fatal and fatal overdoses involving stimulants with and without opioids in the United States. Hoots B., Vivolo-Kantor A., Seth P., p. 946-958. - Commentary on Hoots et al. (2019): The gap between evidence and policy calls into question the extent of a public health approach to the opioid overdose epidemic. Nolan M.L., Allen B., Paone D., p. 959-960. - Association of prevalence of electronic cigarette use with smoking cessation and cigarette consumption in England: a time-series analysis between 2006 and 2017. Beard E., West R., Michie S., Brown J., p. 961-974. - Commentary on Beard et al. (2019): A systematic approach sharpens insights on e-cigarettes and smoking cessation. Villanti A.C., Pearson J.L., p. 975-976. - Comparison of Allen Carr's Easyway programme with a specialist behavioural and pharmacological smoking cessation support service: a randomized controlled trial. Frings D., Albery I.P., Moss A.C., Brunger H., Burghelea M., White S., et al., p. 977-985. - Diffusion of effects of the ASSIST school-based smoking prevention intervention to non-participating family members: a secondary analysis of a randomized controlled trial. White J., Holliday J., Daniel R., Campbell R., Moore L., p. 986-991. - Commentary on White et al. (2019): Future directions in studying the diffusion of intervention effects. Rulison K.L., p. 992-993. |
Cote : | Abonnement |
Lien : | https://onlinelibrary.wiley.com/toc/13600443/2020/115/5 |
Dépouillements
Ajouter le résultat dans votre panierArticle : Périodique
BACKGROUND: Very few countries regulate maximum cigarette pack size. Larger, non-standard sizes are increasingly being introduced by the tobacco industry. Larger portion sizes increase food consumption; larger cigarette packs may similarly incre[...]
Article : Périodique
BACKGROUND AND AIMS: There are growing concerns over the respiratory health of people who use illicit opioids due to high rates of opioid inhalation and tobacco smoking in this group. This study aimed to summarize the evidence relating illicit o[...]
Article : Périodique
N. A. BRETANA ;
R. R. GRAY ;
E. B. CUNNINGHAM ;
B. BETZ-STABLEIN ;
R. RIBEIRO ;
F. GRAW ;
F. LUCIANI ;
A. R. LLOYD
|
BACKGROUND AND AIMS: Australia is currently on track to meet the World Health Organization (WHO) global hepatitis C virus (HCV) elimination goals by 2030, reflecting universal subsidized access to testing and direct-acting antiviral (DAA) treatm[...]
Article : Périodique
Exemplaires
Disponibilité |
---|
aucun exemplaire |
Accueil